4 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-22-026154
Form type: Form 4
Filer: CUMBERLAND PHARMACEUTICALS INC
CIK: CIK 1087294
Filed: Apr 29, 2022
Reporting period: Mar 17, 2022
Description: Insider transaction

Documents

0001209191-22-026154-index.htm

Complete submission

0001209191-22-026154.txt

directory listing

Filed by

CUMBERLAND PHARMACEUTICALS INC